John T. Bigalke - Net Worth and Insider Trading

John T. Bigalke Net Worth

The estimated net worth of John T. Bigalke is at least $609,913 dollars as of 2025-05-03. John T. Bigalke is the Director of Premier Inc and owns about 29,810 shares of Premier Inc (PINC) stock worth over $609,913. Details can be seen in John T. Bigalke's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John T. Bigalke has not made any transactions after 2025-03-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of John T. Bigalke

To

John T. Bigalke Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John T. Bigalke owns 2 companies in total, including Biora Therapeutics Inc (BIOR) , and Premier Inc (PINC) .

Click here to see the complete history of John T. Bigalke’s form 4 insider trades.

Insider Ownership Summary of John T. Bigalke

Ticker Company Transaction Date Type of Owner
BIOR Biora Therapeutics Inc 2020-06-18 director
PINC Premier Inc 2025-03-05 director

John T. Bigalke Latest Holdings Summary

John T. Bigalke currently owns a total of 1 stock. John T. Bigalke owns 29,810 shares of Premier Inc (PINC) as of March 5, 2025, with a value of $609,913.

Latest Holdings of John T. Bigalke

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PINC Premier Inc 2025-03-05 29,810 20.46 609,913

Holding Weightings of John T. Bigalke


John T. Bigalke Form 4 Trading Tracker

According to the SEC Form 4 filings, John T. Bigalke has made a total of 2 transactions in Premier Inc (PINC) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Premier Inc is the sale of 1,137 shares on March 5, 2025, which brought John T. Bigalke around $19,943.

Insider Trading History of John T. Bigalke

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John T. Bigalke Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

John T. Bigalke Ownership Network

Ownership Network List of John T. Bigalke

No Data

Ownership Network Relation of John T. Bigalke

Insider Network Chart


John T. Bigalke Owned Company Details

What does Biora Therapeutics Inc do?

Who are the key executives at Biora Therapeutics Inc?

John T. Bigalke is the director of Biora Therapeutics Inc. Other key executives at Biora Therapeutics Inc include 10 percent owner Athyrium Opportunities Iii Co-invest 1 Lp , director & Chief Executive Officer Aditya P. Mohanty , and 10 percent owner Athyrium Capital Management, Lp .

Biora Therapeutics Inc (BIOR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Biora Therapeutics Inc (BIOR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Biora Therapeutics Inc (BIOR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Biora Therapeutics Inc (BIOR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Biora Therapeutics Inc Insider Transactions

No Available Data

John T. Bigalke Mailing Address

Above is the net worth, insider trading, and ownership report for John T. Bigalke. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, John T. Bigalke's mailing address is: Charlotte Nc 28277.